SPONSOR
JW Pharmaceutical
Total Trials
4
Recruiting
4
Phases
Phase 3, Phase 1
JW Pharmaceutical is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Menorrhagia, Uterine Fibroids, Dyslipidemias, Healthy.
The trial portfolio spans Phase 3, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — JW Pharmaceutical
How many clinical trials has JW Pharmaceutical sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by JW Pharmaceutical, of which 4 are actively recruiting participants. These trials cover conditions including Menorrhagia, Uterine Fibroids, Dyslipidemias. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does JW Pharmaceutical research focus on?
JW Pharmaceutical clinical trials span Menorrhagia, Uterine Fibroids, Dyslipidemias, Healthy, Hypertension, and additional conditions. The research pipeline includes Phase 3, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a JW Pharmaceutical clinical trial?
To participate in a JW Pharmaceutical trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all JW Pharmaceutical trials with current recruitment status updated daily.
Clinical Trials by JW Pharmaceutical
NCT07378098 Phase 3
Recruiting
to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia
Menorrhagia
NCT07523971
Recruiting
Efficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic Syndrome: An Observational Study
Dyslipidemias
NCT07514780 Phase 1
Recruiting
To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy Volunteers
Healthy
NCT06643130 Phase 3
Recruiting
Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia
Hypertension
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology